Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) reached a new 52-week low during trading on Tuesday . The company traded as low as C$0.14 and last traded at C$0.14, with a volume of 262748 shares traded. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Price Performance
The company has a debt-to-equity ratio of 217.41, a quick ratio of 6.67 and a current ratio of 0.28. The company has a market cap of C$22.01 million, a PE ratio of -4.67 and a beta of 0.39. The stock has a 50 day moving average of C$0.16 and a 200-day moving average of C$0.19.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Recommended Stories
- Five stocks we like better than VentriPoint Diagnostics
- What Are Trending Stocks? Trending Stocks Explained
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Insider Buying Explained: What Investors Need to Know
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Effectively Use the MarketBeat Ratings Screener
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
